Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?

Updated international guidelines published in 2006 have broadened the scope for the use of granulocyte colony-stimulating factor (G-CSF) in supporting delivery of myelosuppressive chemotherapy. G-CSF prophylaxis is now recommended when the overall risk of febrile neutropenia (FN) due to regimen and...

Descripción completa

Detalles Bibliográficos
Autores principales: Aapro, Matti, Crawford, Jeffrey, Kamioner, Didier
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846279/
https://www.ncbi.nlm.nih.gov/pubmed/20191292
http://dx.doi.org/10.1007/s00520-010-0816-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846279/
https://www.ncbi.nlm.nih.gov/pubmed/20191292
http://dx.doi.org/10.1007/s00520-010-0816-y

Ejemplares similares